Materials Nexus
Seed Round in 2023
Materials Nexus is a deep-tech company specializing in accelerating sustainable materials innovation. It automates complex quantum calculations at scale, enhancing accuracy and efficiency. The company's core business lies in developing a material modeling platform that integrates quantum mechanics and artificial intelligence. This platform facilitates the creation of greener, more sustainable materials with reduced greenhouse gas emissions, primarily targeting the construction sector for access to eco-friendly building materials.
Phico Therapeutics
Venture Round in 2009
Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, that specializes in developing innovative antibiotics to combat antibacterial resistance. The company utilizes its proprietary SASPject platform, which employs small acid-soluble spore proteins delivered via targetable non-delivery vehicles to specific bacterial strains. Its product portfolio includes SASPject PT3, designed to target Pseudomonas aeruginosa; SASPject PT4 and PT5, which are aimed at Klebsiella pneumonia and Escherichia coli, respectively; and SASPject PT1.2, focused on Staphylococcus aureus. Additionally, Phico Therapeutics is working on an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses in conjunction with antibacterial proteins to inhibit bacterial growth and toxin release. Founded in 2000, the company is dedicated to addressing critical challenges in antibiotic resistance through its advanced therapeutic approaches.
Phico Therapeutics
Venture Round in 2006
Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, that specializes in developing innovative antibiotics to combat antibacterial resistance. The company utilizes its proprietary SASPject platform, which employs small acid-soluble spore proteins delivered via targetable non-delivery vehicles to specific bacterial strains. Its product portfolio includes SASPject PT3, designed to target Pseudomonas aeruginosa; SASPject PT4 and PT5, which are aimed at Klebsiella pneumonia and Escherichia coli, respectively; and SASPject PT1.2, focused on Staphylococcus aureus. Additionally, Phico Therapeutics is working on an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses in conjunction with antibacterial proteins to inhibit bacterial growth and toxin release. Founded in 2000, the company is dedicated to addressing critical challenges in antibiotic resistance through its advanced therapeutic approaches.
Bango
Venture Round in 2002
Bango plc is a technology company based in Cambridge, United Kingdom, specializing in mobile payment solutions for content and services. Founded in 1999, Bango develops, markets, and sells technology that facilitates the marketing and sale of products directly to mobile phone users. The company operates through two segments: End User Activity and Data Activity. Its key offering, the Bango Payment Platform, enables app stores and content providers to establish billing connections with mobile operators globally, thereby streamlining the payment process for users. In addition to this platform, Bango offers products such as Bango Marketplace, which aids developers in targeting specific customer audiences, and Bango Resale, which helps merchants acquire and retain customers through global partnerships. The company also features Audiens, a mobile data exchange platform, and partners with leading global stores and payment providers to enhance user engagement and revenue generation. Bango's operations extend across the United Kingdom, European Union, the United States, Canada, and internationally.
Cyan Technology
Series A in 2000
Cyan Technology Ltd develops and markets ultra low power RISC microcontroller with configurable peripherals.
E-Paper Innovation
Seed Round in 2000
Plastic Logic Ltd is a manufacturer of plastic electronics, specializing in the development and production of flexible displays and devices. The company, based in Cambridge, United Kingdom, and with operations in Dresden, Germany, offers a range of high-quality, lightweight, and shatterproof electrophoretic displays in both color and monochrome. These displays are utilized in various applications, including mobile devices such as smartphones, e-readers, and tablets, as well as in signage, wristwatches, and automotive products. Plastic Logic serves original equipment manufacturers (OEMs), system integrators, and device manufacturers across the UK, Germany, Russia, and other international markets. The company has established a strategic partnership with UST Global Inc. and operates a pioneering facility that serves as the world's first commercial, volume production site for organic electronics. Through its open pilot line, Plastic Logic also collaborates with third-party companies, sharing its expertise in the industrialization and manufacturing of flexible electronics.